ANDOVER, Mass., June 01, 2023 Oncorus, Inc. , an RNA medicines company focused on developing intravenously administered, self-amplifying RNA to transform outcomes for cancer patients, today. | June 1, 2023
Oncorus Announces Workforce Reduction Plan streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
IND submission for ONCR-021 still planned for mid-2023, subject to receipt of additional funding Ended the quarter with $45.0 million in cash, cash equivalents and investments ANDOVER, Mass., May . | May 22, 2023
22.05.2023 - IND submission for ONCR-021 still planned for mid-2023, subject to receipt of additional funding Ended the quarter with $45.0 million in cash, cash equivalents and investments ANDOVER, Mass., May 22, 2023 (GLOBE NEWSWIRE) - Oncorus, Inc. .
Reviews for the real world.
Wirecutter is reader-supported. When you buy through links on our site, we may earn an affiliate commission.Learn more
Real Talk
Illustration: Yann Bastard
Published April 21, 2021
Share this post
My happy place is that chaotic zone of salt and spray where the beach meets the sea, a place of coming and going, flux and exchange. I love to dig my toes into the suctioning sand and feel the swirl of a receding wave. Though often my feet find sharp things in the soft sand not just gravel and pebbles but also, increasingly and overwhelmingly, plastic. I try to collect the shards, the bits of aquas, whites, and teals, but soon I give up, angry and defeated. There is too much. So much of it is too tiny to hold or even see.